InvestorsHub Logo
Followers 12
Posts 1293
Boards Moderated 0
Alias Born 03/12/2020

Re: None

Thursday, 11/18/2021 10:45:52 AM

Thursday, November 18, 2021 10:45:52 AM

Post# of 44377
I’ve been adding on these dips of late. The .07’s are a good add zone imo. Low volume red days between news updates.

Attached is a reminder of the bio of their most recent advisor addition, Dr. Catherine Sohn.

https://www.globenewswire.com/news-release/2021/10/12/2312778/0/en/CURATIVE-BIOTECHNOLOGY-ANNOUNCES-DR-CATHERINE-SOHN-AS-SPECIAL-ADVISOR-TO-BOARD-AND-CEO.html

Key quote from bio:

“Dr. Sohn started the U.S. Vaccine Business for SmithKline Beecham and led the launch of its first vaccine in the U.S. and helped shape their global vaccine portfolio pipeline as a member of the International Vaccine Steering Committee.”

Interesting timing of the company’s announcement of developing a novel Covid-19 vaccine for kidney failure patients (in line with their rare disease strategy) with her joining as an advisor. She started SmithKline Beecham’s vaccine business. Gotta believe she can open some doors and knows the process of developing products.